FR2997014B1 - Composition sterile dermo-injectable - Google Patents

Composition sterile dermo-injectable

Info

Publication number: FR2997014B1
Authority: FR; France
Prior art keywords: dermo; injectable sterile; sterile composition; injectable; composition
Prior art date: 2012-10-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR1260146A

Other languages

English (en)

Other versions

FR2997014A1 (fr

Inventor

Francois Bourdon

Stephane Meunier

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Teoxane SA

Original Assignee

Teoxane SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-24

Filing date

2012-10-24

Publication date

2015-03-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47754646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2997014(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-10-24 Application filed by Teoxane SA filed Critical Teoxane SA

2012-10-24 Priority to FR1260146A priority Critical patent/FR2997014B1/fr

2013-10-24 Priority to PCT/IB2013/059607 priority patent/WO2014064632A1/fr

2013-10-24 Priority to BR112015009162-8A priority patent/BR112015009162B1/pt

2013-10-24 Priority to TR2019/11149T priority patent/TR201911149T4/tr

2013-10-24 Priority to PT13820892T priority patent/PT2912074T/pt

2013-10-24 Priority to CA2888616A priority patent/CA2888616C/fr

2013-10-24 Priority to ES13820892T priority patent/ES2735017T5/es

2013-10-24 Priority to US14/437,917 priority patent/US9907739B2/en

2013-10-24 Priority to RU2015118969A priority patent/RU2653729C2/ru

2013-10-24 Priority to KR1020157013662A priority patent/KR102178252B1/ko

2013-10-24 Priority to AU2013336274A priority patent/AU2013336274B2/en

2013-10-24 Priority to PL13820892T priority patent/PL2912074T5/pl

2013-10-24 Priority to DK13820892.1T priority patent/DK2912074T4/da

2013-10-24 Priority to EP13820892.1A priority patent/EP2912074B2/fr

2013-10-24 Priority to SI201331513T priority patent/SI2912074T1/sl

2013-10-24 Priority to JP2015538611A priority patent/JP6521862B2/ja

2013-10-24 Priority to HRP20191196TT priority patent/HRP20191196T1/hr

2013-10-24 Priority to HUE13820892 priority patent/HUE044362T2/hu

2013-10-24 Priority to RS20190862A priority patent/RS59079B1/sr

2014-04-25 Publication of FR2997014A1 publication Critical patent/FR2997014A1/fr

2015-03-20 Publication of FR2997014B1 publication Critical patent/FR2997014B1/fr

2015-03-20 Application granted granted Critical

2018-01-18 Priority to US15/874,144 priority patent/US10307362B2/en

Status Active legal-status Critical Current

2032-10-24 Anticipated expiration legal-status Critical

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Polymers & Plastics (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Materials Engineering (AREA)
Pharmacology & Pharmacy (AREA)
Dispersion Chemistry (AREA)
Gerontology & Geriatric Medicine (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Compositions Of Macromolecular Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

FR1260146A 2012-10-24 2012-10-24 Composition sterile dermo-injectable Active FR2997014B1 (fr)

Priority Applications (20)

Application Number	Priority Date	Filing Date	Title
FR1260146A FR2997014B1 (fr)	2012-10-24	2012-10-24	Composition sterile dermo-injectable
AU2013336274A AU2013336274B2 (en)	2012-10-24	2013-10-24	Dermal injectable sterile composition
DK13820892.1T DK2912074T4 (da)	2012-10-24	2013-10-24	Dermal injicerbar steril sammensætning
TR2019/11149T TR201911149T4 (tr)	2012-10-24	2013-10-24	Dermal enjekte edilebilir steril bileşim.
PT13820892T PT2912074T (pt)	2012-10-24	2013-10-24	Composição estéril injetável dérmica
CA2888616A CA2888616C (fr)	2012-10-24	2013-10-24	Composition sterile dermo-injectable
ES13820892T ES2735017T5 (es)	2012-10-24	2013-10-24	Composición dérmica inyectable estéril
US14/437,917 US9907739B2 (en)	2012-10-24	2013-10-24	Dermal injectable sterile composition
RU2015118969A RU2653729C2 (ru)	2012-10-24	2013-10-24	Дермальная инъецируемая стерильная композиция
KR1020157013662A KR102178252B1 (ko)	2012-10-24	2013-10-24	피부 주사가능한 멸균 조성물
PCT/IB2013/059607 WO2014064632A1 (fr)	2012-10-24	2013-10-24	Composition stérile dermo-injectable
PL13820892T PL2912074T5 (pl)	2012-10-24	2013-10-24	Sterylna kompozycja do wstrzykiwania przez skórę
BR112015009162-8A BR112015009162B1 (pt)	2012-10-24	2013-10-24	Gel de ácido hialurônico reticulado, processo para preparar um gel de ácido hialurônico reticulado, composições dermatológicas, kit e uso de um gel de ácido hialurônico reticulado
EP13820892.1A EP2912074B2 (fr)	2012-10-24	2013-10-24	Composition stérile dermo-injectable
SI201331513T SI2912074T1 (sl)	2012-10-24	2013-10-24	Dermalni sterilni sestavek za injiciranje
JP2015538611A JP6521862B2 (ja)	2012-10-24	2013-10-24	皮膚用の注入可能な滅菌組成物
HRP20191196TT HRP20191196T1 (hr)	2012-10-24	2013-10-24	Dermalni injektivni sterilni pripravak
HUE13820892 HUE044362T2 (hu)	2012-10-24	2013-10-24	Dermálisan injekciózható steril készítmény
RS20190862A RS59079B1 (sr)	2012-10-24	2013-10-24	Dermalni injekcioni sterilni sastav
US15/874,144 US10307362B2 (en)	2012-10-24	2018-01-18	Dermal injectable sterile composition

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR1260146A FR2997014B1 (fr)	2012-10-24	2012-10-24	Composition sterile dermo-injectable

Publications (2)

Publication Number	Publication Date
FR2997014A1 FR2997014A1 (fr)	2014-04-25
FR2997014B1 true FR2997014B1 (fr)	2015-03-20

Family

ID=47754646

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR1260146A Active FR2997014B1 (fr)	2012-10-24	2012-10-24	Composition sterile dermo-injectable

Country Status (19)

Country	Link
US (2)	US9907739B2 (fr)
EP (1)	EP2912074B2 (fr)
JP (1)	JP6521862B2 (fr)
KR (1)	KR102178252B1 (fr)
AU (1)	AU2013336274B2 (fr)
BR (1)	BR112015009162B1 (fr)
CA (1)	CA2888616C (fr)
DK (1)	DK2912074T4 (fr)
ES (1)	ES2735017T5 (fr)
FR (1)	FR2997014B1 (fr)
HR (1)	HRP20191196T1 (fr)
HU (1)	HUE044362T2 (fr)
PL (1)	PL2912074T5 (fr)
PT (1)	PT2912074T (fr)
RS (1)	RS59079B1 (fr)
RU (1)	RU2653729C2 (fr)
SI (1)	SI2912074T1 (fr)
TR (1)	TR201911149T4 (fr)
WO (1)	WO2014064632A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6906885B2 (ja)	2014-11-14	2021-07-21	ロレアル	しわを減少させるためのマイクロニードルシート
FR3034195B1 (fr)	2015-03-24	2017-04-21	Teoxane	Procede d'evaluation des performances mecaniques d'un gel de comblement
PT3397648T (pt)	2015-12-29	2020-08-26	Galderma Sa	Método de desacetilação de biopolímeros
AU2016426150B2 (en) *	2016-10-13	2022-06-30	Allergan, Inc.	Coacervate hyaluronan hydrogels for dermal filler applications
EP3562468A1 (fr) *	2016-12-29	2019-11-06	Nestlé Skin Health SA	Vésicules multilamellaires micro- ou nanoparticulaires, compositions les comprenant et leur procédé d'utilisation dans les soins de la peau
WO2018122343A1 (fr)	2016-12-29	2018-07-05	Nestlé Skin Health Sa	Vésicules micro- ou nanoparticulaires comprenant de l'acide hyaluronique réticulé, compositions les comprenant et leur méthode d'utilisation dans les soins de la peau
WO2018122344A1 (fr)	2016-12-29	2018-07-05	Nestlé Skin Health Sa	Composition comprenant un acide hyaluronique (ah) réticulé en combinaison avec un ah de faible poids moléculaire et/ou un agent stimulant la synthèse d'ah endogène
CN111727033A (zh) *	2018-02-16	2020-09-29	东洋纺株式会社	防污染剂及皮肤外用组合物
MX2020013000A (es)	2018-06-15	2021-03-29	Croma Pharma Gmbh	Composicion de hidrogel que comprende polimero reticulado.
KR20210021361A (ko)	2018-06-15	2021-02-25	크로마-파르마 게엠베하	가교된 폴리머를 포함하는 히드로겔 조성물
EP3813584A2 (fr)	2018-06-29	2021-05-05	The Procter & Gamble Company	Produits à deux phases
CN112384307B (zh)	2018-06-29	2023-06-16	宝洁公司	双相产品分配器
KR20210008860A (ko)	2018-06-29	2021-01-25	더 프록터 앤드 갬블 캄파니	이중상 제품
EP3813768A2 (fr)	2018-06-29	2021-05-05	The Procter & Gamble Company	Produits à deux phases
RS66897B1 (sr) *	2018-07-06	2025-07-31	Lg Chemical Ltd	Filer hijaluronske kiseline visoke viskoelastičnosti i visoke kohezivnosti
WO2020013580A1 (fr) *	2018-07-10	2020-01-16	주식회사 엘지화학	Produit de comblement à base d'acide hyaluronique présentant une capacité de comblement élevée et ne nécessitant qu'une faible force d'injection
KR102566287B1 (ko) *	2018-11-30	2023-08-11	주식회사 엘지화학	히알루론산을 포함하는 활액보충재용 조성물
CN113164652B (zh) *	2018-12-20	2023-02-21	株式会社Lg化学	具有优异的填充剂性能的包含透明质酸水凝胶的填充剂
JP1665824S (fr)	2019-08-21	2020-08-11
US11497703B2 (en) *	2019-08-30	2022-11-15	The Procter & Gamble Company	Packaged hair care composition
CA3157952A1 (fr)	2019-12-19	2021-06-24	Ralph Hollaus	Hyaluronane modifie par thiol et hydrogel comprenant l'hyaluronane reticule
WO2022094553A1 (fr)	2020-10-27	2022-05-05	The Procter & Gamble Company	Conditionneur chauffant
USD1006632S1 (en)	2020-12-11	2023-12-05	The Procter & Gamble Company	Container for hair care products
USD1012718S1 (en)	2020-12-21	2024-01-30	The Procter & Gamble Company	Container for hair care product
WO2022217069A1 (fr) *	2021-04-09	2022-10-13	Colorado School Of Mines	Gels zwitterioniques réticulés par voie radicalaire et leurs utilisations
CN113896915B (zh) *	2021-11-10	2024-02-13	爱美客技术发展股份有限公司	一种凝胶材料及其制备方法与应用
KR20240105428A (ko) *	2021-11-10	2024-07-05	아이메이커 테크놀러지 디벨롭먼트 캄파니 리미티드	겔 재료 및 이의 제조 방법과 응용
JP2024542665A (ja) *	2021-11-29	2024-11-15	▲愛▼美客技▲術▼▲発▼展股▲ふん▼有限公司	複合ゲル、調製方法及び応用
EP4448588A1 (fr)	2022-01-11	2024-10-23	WiQo S.p.A.	Nouveaux dérivés d'acides hyaluroniques en tant que combleurs innovants
WO2023221082A1 (fr) *	2022-05-20	2023-11-23	爱美客技术发展股份有限公司	Matériau polymère greffé, procédé de préparation associé et son application
CN118574873A (zh) *	2022-08-24	2024-08-30	爱美客技术发展股份有限公司	一种凝胶材料及其制备方法
CN119286070A (zh) *	2024-10-30	2025-01-10	陕西科技大学	一种基于铜离子交联改性的透明质酸水凝胶及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2752843B1 (fr) †	1996-08-30	1998-10-16	Sod Conseils Rech Applic	Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303735B1 (it)	1998-11-11	2001-02-23	Falorni Italia Farmaceutici S	Acidi ialuronici reticolati e loro usi medici.
KR100375299B1 (ko) †	2000-10-10	2003-03-10	주식회사 엘지생명과학	히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
US20040162235A1 (en) *	2003-02-18	2004-08-19	Trubetskoy Vladimir S.	Delivery of siRNA to cells using polyampholytes
US8524213B2 (en)	2003-12-30	2013-09-03	Genzyme Corporation	Polymeric materials, their preparation and use
NO20044818D0 (no)	2004-11-05	2004-11-05	Bioforsk As	Spermin i kosmetiske preparater
US20060105022A1 (en)	2004-11-15	2006-05-18	Shiseido Co., Ltd.	Process for preparing crosslinked hyaluronic acid gel
PL1817347T3 (pl)	2004-11-24	2017-10-31	Albumedix As	Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu
EP1884231A1 (fr)	2006-08-01	2008-02-06	Auriga International S.A.	Composition cosmétique ou pharmaceutique contenant acide hyaluronique
FR2908415B1 (fr) †	2006-11-10	2009-01-23	Abr Dev Sarl	Acide hyaluronique reticule et son procede de preparation
US20110256059A1 (en)	2008-10-28	2011-10-20	Universidade De Santiago De Compostela	Nanoparticulate systems prepared from anionic polymers
FR2945293B1 (fr) *	2009-05-11	2011-06-17	Teoxane	Procede de preparation d'un gel reticule.
ES2368307B1 (es) *	2010-04-28	2012-10-17	Universidade De Santiago De Compostela	Hidrogeles elaborados a base de polímeros aniónicos de origen natural.
US9017712B2 (en) *	2010-07-12	2015-04-28	Shin Poong Pharmaceutical Co., Ltd.	Filler composition for tissue reinforcement

2012
- 2012-10-24 FR FR1260146A patent/FR2997014B1/fr active Active
2013
- 2013-10-24 HU HUE13820892 patent/HUE044362T2/hu unknown
- 2013-10-24 CA CA2888616A patent/CA2888616C/fr active Active
- 2013-10-24 BR BR112015009162-8A patent/BR112015009162B1/pt active IP Right Grant
- 2013-10-24 HR HRP20191196TT patent/HRP20191196T1/hr unknown
- 2013-10-24 JP JP2015538611A patent/JP6521862B2/ja active Active
- 2013-10-24 AU AU2013336274A patent/AU2013336274B2/en active Active
- 2013-10-24 RU RU2015118969A patent/RU2653729C2/ru active
- 2013-10-24 TR TR2019/11149T patent/TR201911149T4/tr unknown
- 2013-10-24 WO PCT/IB2013/059607 patent/WO2014064632A1/fr not_active Ceased
- 2013-10-24 US US14/437,917 patent/US9907739B2/en active Active
- 2013-10-24 KR KR1020157013662A patent/KR102178252B1/ko active Active
- 2013-10-24 EP EP13820892.1A patent/EP2912074B2/fr active Active
- 2013-10-24 SI SI201331513T patent/SI2912074T1/sl unknown
- 2013-10-24 ES ES13820892T patent/ES2735017T5/es active Active
- 2013-10-24 RS RS20190862A patent/RS59079B1/sr unknown
- 2013-10-24 DK DK13820892.1T patent/DK2912074T4/da active
- 2013-10-24 PL PL13820892T patent/PL2912074T5/pl unknown
- 2013-10-24 PT PT13820892T patent/PT2912074T/pt unknown
2018
- 2018-01-18 US US15/874,144 patent/US10307362B2/en active Active

Also Published As

Publication number	Publication date
JP6521862B2 (ja)	2019-05-29
PL2912074T5 (pl)	2022-04-04
PT2912074T (pt)	2019-07-19
JP2016507592A (ja)	2016-03-10
US20150272851A1 (en)	2015-10-01
DK2912074T4 (da)	2022-03-14
EP2912074B1 (fr)	2019-05-01
SI2912074T1 (sl)	2019-08-30
HRP20191196T1 (hr)	2019-10-18
HUE044362T2 (hu)	2019-10-28
CA2888616A1 (fr)	2014-05-01
TR201911149T4 (tr)	2019-08-21
KR102178252B1 (ko)	2020-11-13
PL2912074T3 (pl)	2019-09-30
BR112015009162B1 (pt)	2021-10-13
US9907739B2 (en)	2018-03-06
AU2013336274B2 (en)	2017-08-24
KR20150079786A (ko)	2015-07-08
ES2735017T3 (es)	2019-12-13
CA2888616C (fr)	2020-09-15
AU2013336274A1 (en)	2015-05-07
RS59079B1 (sr)	2019-09-30
RU2653729C2 (ru)	2018-05-14
ES2735017T5 (es)	2022-04-28
EP2912074B2 (fr)	2021-12-22
FR2997014A1 (fr)	2014-04-25
RU2015118969A (ru)	2016-12-20
EP2912074A1 (fr)	2015-09-02
DK2912074T3 (da)	2019-07-22
US10307362B2 (en)	2019-06-04
WO2014064632A1 (fr)	2014-05-01
BR112015009162A2 (pt)	2017-10-03
US20180140530A1 (en)	2018-05-24

Publication	Publication Date	Title
FR2997014B1 (fr)	2015-03-20	Composition sterile dermo-injectable
DK3858405T3 (da)	2023-07-03	Sprøjte
DK3685826T3 (da)	2022-02-14	Sprøjte
PT3725778T (pt)	2021-09-22	Formulações de enzalutamida
EP2807309A4 (fr)	2016-05-25	Crépine de vidange
BR112014032798A2 (pt)	2017-06-27	composição
EP2832391A4 (fr)	2015-10-28	Seringue
DE112012006109A5 (de)	2014-12-18	Okklusionsschienenanordnung
ME03413B (fr)	2020-01-20	Compositions
EP2934132A4 (fr)	2016-08-17	Désinfectant
EP2812047A4 (fr)	2015-10-21	Système d'accès via une occlusion
DK2897594T3 (da)	2020-06-29	Farmaceutisk sammensætning
EP2913076A4 (fr)	2016-08-17	Seringue
EP2920370A4 (fr)	2016-08-03	Montant
EP2931176A4 (fr)	2016-10-26	Fronde médicale
EP2851085A4 (fr)	2015-04-15	Composition stérilisée
BR112014032712A2 (pt)	2017-06-27	composição
EP2855590A4 (fr)	2016-02-24	Composition polymère
HUE049445T2 (hu)	2020-09-28	Új kompozíciók
DE112012005566T8 (de)	2014-11-13	Seltenerdnanoverbundmagnet
EP2837670A4 (fr)	2016-01-13	Composition contenant un fluorobiphényle
DK2811828T3 (da)	2021-11-15	Adjuvanssammensætninger
DE102013212400A8 (de)	2014-08-21	Abdeckplattenstützbaugruppe
DK2800573T3 (da)	2021-06-28	Oftalmologisk sammensætning
DE102012100780A8 (de)	2013-10-02	Zugmittelhebevorrichtung

Legal Events

Date	Code	Title	Description
2016-08-31	PLFP	Fee payment	Year of fee payment: 5
2017-08-30	PLFP	Fee payment	Year of fee payment: 6
2018-08-30	PLFP	Fee payment	Year of fee payment: 7
2019-09-30	PLFP	Fee payment	Year of fee payment: 8
2020-08-26	PLFP	Fee payment	Year of fee payment: 9
2021-08-24	PLFP	Fee payment	Year of fee payment: 10
2022-09-28	PLFP	Fee payment	Year of fee payment: 11
2023-08-24	PLFP	Fee payment	Year of fee payment: 12
2024-10-21	PLFP	Fee payment	Year of fee payment: 13
2025-10-29	PLFP	Fee payment	Year of fee payment: 14